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Abstract  26 
Ensuring patient access to genomic information in the face of increasing demand requires 27 
clinicians to develop innovative ways of working. This paper presents the first empirical 28 
prospective observational cohort study of UK multi-disciplinary genetic service delivery. It 29 
describes and explores collaborative working practices including the utilisation and role of 30 
clinical geneticists and non-medical genetic counsellors. Six hundred and fifty new patients 31 
referred to a regional genetics service were tracked through 850 clinical contacts until 32 
discharge. Referral decisions regarding allocation of lead health professional assigned to the 33 
case were monitored, including the use of initial clinical contact guidelines.  Significant 34 
differences were found in the cases led by genetic counsellors and those led by clinical 35 
geneticists. Around a sixth, 16.8% (109/650) of referrals were dealt with by a letter back to 36 
the referrer or re-directed to another service provider and 14.8% (80/541) of the remaining 37 
patients chose not to schedule an appointment. Of the remaining 461 patients, genetic 38 
counsellors were allocated as lead health professional for 46.2% (213/461). A further 61 39 
patients did not attend. Of those who did, 86% (345/400) were discharged after one or two 40 
appointments. Genetic counsellors contributed to 95% (784/825) of total patient contacts. 41 
They provided 93.7% (395/432) of initial contacts and 26.8% (106/395) of patients were 42 
discharged at that point.  The information from this study informed a planned service re-43 
design.  More research is needed to assess the effectiveness and efficiency of different models 44 
of collaborative multi-disciplinary working within genetics services. Keywords (MeSH terms) 45 
Genetic Services, Genetic Counseling, Interdisciplinary Communication, Cohort Studies, 46 
Delivery of Healthcare, Referral and Consultation. 47 
 48 
Introduction 49 
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Over the last few years advances in technology have resulted in a rapid increase in the number 50 
of gene tests available. In parallel there has been an increase in the number of referrals to 51 
genetic services due to heightened public and health professional awareness of the potential 52 
of genomic information1,2. Recent work indicates that workforce interventions within service 53 
re-organisation; including telephone counselling by genetic counsellors 3, the provision of 54 
more genetic specialists in rural areas 4and changes to the referral management systems 5 55 
can have a significant effect on the ability of patients to access genetic service6,7. A systematic 56 
literature review, entitled “Interventions to improve patient access, service utilization and 57 
cost of providing genetic counselling services” is currently planned 7.  58 
 59 
The present study describes the usual care pathways of a UK regional genetics service in 2011-60 
2012. One study aim was to monitor the use of recently introduced new initial clinical contact 61 
guidelines (ICCG) with the aim of reducing the proportion of home visits and increasing the 62 
proportion of telephone contacts. The service provided 26% of its initial contacts by a home 63 
visit in 2010-2011. 64 
 65 
Within UK regional genetic services clinical patient contact is provided by a multidisciplinary 66 
team “a team of professionals including representatives of different disciplines who 67 
coordinate the contributions of each profession, which are not considered to overlap, in order 68 
to improve patient care” 8.  Disciplines represented Include medical professionals (clinical 69 
geneticists), genetic counsellor professionals (genetic counsellors) and nursing professionals 70 
(registered nurses) 9.   71 
 72 
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A systematic review of research literature investigating the role of the non-medical genetic 73 
counsellor indicated that genetic counsellors, “undertake a significant workload associated 74 
with direct patient care and this appears to be acceptable to patients” 10.  The proportion of 75 
patients seen by genetic counsellors without a medical practitioner being present ranged 76 
between 39% and 50% and included patients with up to 79 different conditions.  However no 77 
empirical research studies of the genetic counsellor role were found from any of the European 78 
countries. Therefore one aim of this research was to investigate the proportion of patients 79 
allocated to each discipline and provide evidence of multidisciplinary working practices. 80 
Optimisation of workforce skill-mix could increase the capacity of genetic services, enabling 81 
improved access for patients.   82 
 83 
Currently the utilization of non-medical genetic counsellors varies across Europe and many 84 
countries only have a small number of practitioners11. In order to safeguard the public and 85 
standardise practice, the European Board of Medical Genetics has defined a code of practice 86 
and registration system for genetic counsellors across Europe12. English regional genetic 87 
services receive centralised funding13. The services are provided free to patients at the point 88 
of access. The NHS England Medical Genetics Clinical Reference Group has responsibility for 89 
defining English service specifications and outcomes for the 23 regional genetics services14. 90 
UK genetic counsellor professional registration is regulated by the UK and Eire Genetic 91 
Counsellor Registration Board. It is based on the principle that in addition to prior academic 92 
and vocational qualifications, registered genetic counsellors are required to have a 2-year 93 
training period and a Masters level portfolio assessment to become appropriately 94 
competent15. In 2011 there were 272 genetic counsellor positions in the UK, but not all 95 
practitioners were registered with the GCRB 16. The current number of practitioners is 96 
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unknown but 186 are UK Genetic Counsellor Board Registered. The majority working as part 97 
of a multi-disciplinary team attached to regional genetics services17.   98 
 99 
The situation across Europe is complicated by differing economic policy, healthcare 100 
professional roles, cultural preferences and political systems. Patient surveys show that there 101 
is great variability in access to genetic healthcare for diagnosis and on-going treatment 18;19. 102 
To meet this demand clinicians are moving away from established models of service delivery 103 
and are developing innovative ways of working such as the integration of genetic and genomic 104 
testing within mainstream clinical specialty areas20. This refinement of skill mix and workforce 105 
optimisation has been seen within other areas of healthcare typified by rising consumer 106 
demand and limited resources21-23. Historically the UK non-medical genetic service workforce 107 
provided psychosocial support and counselling which originated in many services from a 108 
community family nursing perspective. This aimed to provide on-going holistic care to families 109 
affected by genetic conditions. This focus on continuity of care in a community setting has 110 
meant that some services still retain the option of offering a home visit in certain 111 
circumstances if indicated by local protocols. This study was designed to describe practice 112 
within a regional genetics service and aimed to: 113 
• Determine the proportion of patients allocated to clinical geneticist or genetic 114 
counsellor led care. 115 
• Assess the usefulness of initial clinical contact guidelines (ICCG) to aid allocation of 116 
telephone, clinic or home visit for the initial contact.  117 
• Describe the range of clinical contacts within a regional genetics service. 118 
 119 
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• Explore whether a genetic patient reported outcome measures questionnaire24 and a 120 
patient satisfaction questionnaire25 can be incorporated into service provision. 121 
Methods 122 
This observational prospective cohort study was undertaken in a UK regional genetics 123 
service serving a population of 2.7 million, with 3.9 full-time equivalent consultant clinical 124 
geneticists, 9.3 full-time equivalent genetic counsellors and 1 full-time equivalent genetic 125 
research nurse. This regional genetics service works closely with a local network of nurse-led 126 
breast cancer family history clinics which provide genetic counselling for patients at low or 127 
moderate familial breast cancer risk. The service hosts a genetics practice development unit 128 
promoting collaborative working between medical staff, genetic counsellors, administrators 129 
and management 26. The study describes the usual care pathways (apart from the 130 
administration of the evaluation questionnaires) present in this service at the time.  131 
Autonomous practice is defined in this study as ‘a genetic counsellor working as part of a 132 
multi-disciplinary team, seeing patients independently and taking personal accountability 133 
for their actions’. The study was approved as a service evaluation by the hospital Research 134 
and Development office. Participants. The study included new patients referred to the 135 
service between the 12th December 2011 and 12th March 2012. This period was chosen 136 
pragmatically due to funding constraints.  A consecutive series of 650 new patient referrals 137 
(i.e. 650 patients) were followed up until discharge (end of care episode) or until the 12th 138 
March 2013. If the referral was for a child, this counted as one patient for this study. The 139 
parents were usually seen by the clinical team at the same time as the child.  140 
Referral management and triage process. A study tracking sheet was attached to each 141 
patient file throughout their episode of care and staff entered the date and outcome for 142 
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each contact.  Data from this sheet was entered by the study administrator into a study 143 
database and this was used to prompt the administration of the patient reported outcome 144 
measure24 and patient satisfaction questionnaire25. Data validation was undertaken by cross 145 
checking the study database information with patient notes and with the hospital patient 146 
information system. Outcomes included: patient group (paediatric, prenatal, adult non-147 
cancer and adult cancer), allocation of health professional case lead, triage allocation, type 148 
of initial clinical contact offered and were formal appointments made between the hospital 149 
administration and the patient (telephone, face to face in clinic, home visit) and number of 150 
contacts per care episode.  151 
The referral letter was reviewed by a two person on-call team consisting of a clinical geneticist 152 
and a genetic counsellor who independently completed a referral management form 153 
(supplementary material 1). The decision making process included whether to accept or 154 
decline the referral. Decline options included: decline with reasons; write back for more 155 
information or send the referral letter to another healthcare service provider. Accepted 156 
referrals were allocated by the above on-call team to either genetic counsellor or consultant 157 
geneticist led care. Any discrepancies in allocations were discussed enabling both professional 158 
viewpoints to be expressed.   159 
 160 
The genetic counsellor then allocated an initial clinical contact at either a telephone clinic, 161 
face to face appointment in a clinic setting or home visit according to a set of existing initial 162 
clinical contact guidelines (ICCG). These guidelines were developed prior to the study by the 163 
genetic counsellor clinical team and considered the psychological, medical and social factors 164 
supplied in the referral letter. The referral was allocated one of 20 triage allocation categories 165 
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which then determined the type of initial clinical contact offered to the patient 166 
(supplementary material 2). The patient was sent a letter and a brochure explaining genetic 167 
counselling to inform their decision whether or not to opt into the service.  This is standard 168 
practice in the service (supplementary material 3 and 4).  169 
 170 
Patient questionnaires. The study aimed to determine if two self-reported questionnaires 171 
could be integrated into routine care and be used to evaluate the service. The Genetic 172 
Counselling Outcomes Scale – 24 (GCOS-24) was developed for use as a patient reported 173 
outcome measure (PROM) within clinical genetics services and has been shown to be valid, 174 
reliable and sensitive to change. The GCOS-24 score measures change in emotional, cognitive, 175 
decisional and behavioural control, as well as emotional regulation and hope24. The Zellerino 176 
seven item questionnaire was used to assess patient satisfaction after using clinical genetic 177 
services, this has been shown to have face validity and good internal consistency25. The GCOS-178 
24 was mailed to patients before and after clinical contact. The satisfaction questionnaire was 179 
mailed after each contact. No questionnaire reminders were sent. 180 
Results 181 
Referral management and triage. Figure 1 shows the patient pathways followed by 650 new 182 
patients. One hundred and nine referrals (109/650, 16.8%) did not meet the referral 183 
guidelines for the service and a letter was sent back to the referrer.  In some of these cases 184 
alternative service providers were suggested such as nurse-led breast cancer family history 185 
clinics. All of the remaining 541 patients were sent a letter asking them to contact the hospital 186 
administration to schedule an initial clinical contact. Eighty (14.8%) chose not to contact the 187 
service to make an appointment. This left 461 patients who were accepted by the service and 188 
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who decided to opt-in, to whom 825 clinical contacts were offered 7.4% (61/825) of which 189 
were not attended .Types of patients included 36.3% paediatric (236/650), 4.5% prenatal 190 
(29/650), 23.8% adult non-cancer (155/650) and 35.4% adult cancer (230/650).  191 
Figure 1 here. 192 
Lead health professional. Approximately half the patients, 47.8% (203/461) were triaged to 193 
a genetic counsellor as the professional lead. The majority of patients (432/461, 93.7%), 194 
including those triaged to clinical geneticist lead, were seen initially by a genetic counsellor. 195 
For 26.8% (106/395) of the patients who attended this was their only contact with the service, 196 
with the genetic counsellor able to complete the episode of care and discharge the patient.  197 
Genetic counsellors contributed to 95% (784/825) of the total contacts; a clinical geneticist 198 
was present in 26.9% (222/825). Only 5% (41/825) of contacts were with a clinical geneticist 199 
working alone in clinic compared to 65.7% (542/825) for genetic counsellors working alone in 200 
clinic. 201 
 202 
Table 1 shows the decision outcome for triage allocation to lead professional and type of 203 
initial clinical contact offered according to the patient categories included within the initial 204 
clinical contact guidelines (ICCG). The categories which were more often (p <0.005) triaged to 205 
clinical geneticist lead included; ‘where a member of the patients family had previously been 206 
seen and information known’ (GC: 5/25 20%, CG: 20/25 80%), ‘paediatric patients with and 207 
without developmental delay’ (GC: 5/35 14.3%, CG: 30/35 85.7%), ‘out-reach clinics’ (GC: 5/20 208 
25%, CG:15/20 75%) and ‘where there was a new significant diagnosis in the family’ (GC: 2/22 209 
9.1%, CG: 20/22 90.9%). Those more often (p <0.001) triaged to genetic counsellor lead 210 
included ‘inherited cardiac diseases’ GC: 29/34 85.3%, CG: 5/34 14.7%), ‘cancer predictive 211 
10 
 
testing’ (GC: 30/40 75%, CG: 10/40 25%) and ‘any adult referral which did not fall into another 212 
category’ (GC: 87/126 69%, CG:39/126 31%).  213 
 214 
Range and type of clinical contacts. Table 1 shows that the initial contact type offered 215 
matched well with those dictated by the initial clinical contact guidelines (figure 1). For 426 216 
of the 461 ( for whom triage allocation patient category and initial contact details were 217 
available) 39.3% were offered a telephone clinic (TC) with a genetic counsellor, 42% a hospital 218 
face to face clinic (F2F) with a genetic counsellor, 13.2% a home visit (HV) with a genetic 219 
counsellor and 4.9% a medical clinic with a clinical geneticist.  220 
Table 1 here.   221 
 222 
Table 2 shows the proportion of co-counselling, where either two genetic counsellors or a 223 
genetic counsellor and a clinical geneticist were present with both contributing to the 224 
counselling process for the duration of the patient consultation. The overall rate of co-225 
counselling in this study was 29.3% (242/825), with the genetic counsellor and clinical 226 
geneticist co-counselling in 21.9% and two genetic counsellors co-counselling in 7.4% of 227 
consultations. The latter mainly represents genetic counsellor-led predictive testing for 228 
cancer and cardiac conditions. Overall, 86% (345/400) of patients who attended their 229 
appointments completed their episode of care and were discharged after one or two 230 
appointments. Only 6.7% (55/825) and 1.9% (16/825) of total contacts received third and 231 
fourth appointments. 232 
Table 2 here. 233 
Patient questionnaires. Developing a robust process which allowed integration of evaluation 234 
questionnaires into routine service delivery proved problematic. This stemmed from 235 
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problems with patient identification at baseline and the end of care. Only 388 out of a possible 236 
850 satisfaction questionnaires were sent out. Ninety-seven were received (response rate 237 
25%). This selected group of patients were satisfied by the care received by their health 238 
professional with greater than 80% stating that they ‘agree somewhat’ or ‘strongly agree’ to 239 
six out of seven questions covering; information provided, time spent, ability to answer 240 
questions, listening and engaging the patient as a partner in planning care (Figure 2).   241 
 242 
Implementation of the questionnaires in a clinical setting was challenging. Issues identified 243 
included: a centralised clinic administration system shared with other departments and no 244 
additional resources to compensate for administration time identifying study cohort patients 245 
during the follow up period. Difficulties tracking follow up patients with the hospital patient 246 
management system meant that a reliable estimate of questionnaires sent and response rate 247 
was not possible. Only 38 pre- and post-genetic counselling GCOS-24 questionnaires were 248 
available for analysis. Those analysed showed a statistically significant difference between 249 
baseline and follow-up score (mean baseline score = 106.5, mean post-care episode score 250 
116.1, p = 0.007 df 37), indicating that this sub-set of patients reported significant benefits 251 
from their contact with the genetics service27.  252 
Figure 2 here. 253 
Discussion 254 
The proportion of patients allocated to clinical geneticist or genetic counsellor care. 255 
The genetic counsellors in this study led patient care for a range of genetic conditions. 256 
However, they did not take the lead for paediatric patients with developmental delay or 257 
patients with new significant diagnoses.  The service did not have a ‘specific’ list of genetic 258 
diagnoses which were suitable for genetic counsellor led care; often this allocation was 259 
12 
 
dependent on the information provided in the individual patient referral letter. The decision 260 
making process seemed to be driven by whether there was evidence of diagnostic uncertainty 261 
or a complex medical phenotype (allocation to clinical geneticist lead) or psychological or 262 
social issues in a family with a known diagnosis (allocation to genetic counsellor lead). This 263 
supports evidence from Skirton et al.’s systematic review of current non-medical genetic 264 
counsellor practice10. This found that the majority of genetic counsellors working in other 265 
countries did not autonomously counsel cases where the diagnosis was uncertain or there 266 
was a need for a clinical examination10.   267 
 268 
The genetic counsellors in this study provided 73% (603/825) of the total offered contacts, as 269 
either genetic counsellor only contacts or genetic counsellor co-counselled contacts. There is 270 
similar evidence from the US where one study reports the motivation to initiate an 271 
independent genetic counsellor clinic was to relieve the pressure on the clinical geneticist’s 272 
clinic28. In that study, 80% of the 321 patients seen did not need an additional appointment 273 
with a geneticist. In Australia, a descriptive retrospective analysis of 4817 cases saw that 42% 274 
of sessions in one region were conducted by the genetic counsellor alone29. In South Africa 275 
genetic counsellors independently saw 39% of the 3365 referred patients covering 57 276 
different diagnoses30. The current study did not explore the health professional allocation 277 
decision making process in-depth and this is a potential area for further research. 278 
 279 
The range of Clinical Contacts 280 
In only 5% (41/825) of contacts did medical clinical geneticists provide counselling by 281 
themselves. The 55.9% (258/461) of the patients who required a clinical geneticist led 282 
consultation in this service would have usually been seen independently by a genetic 283 
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counsellor prior to scheduling a 2nd clinical contact as a genetic counsellor/clinical geneticists 284 
co-counselling contact.   However the rates of clinical geneticist and genetic counsellor co-285 
counselling contacts in this regional genetics service were higher than the National average 286 
at 21.9% (181/825) vs 9.9% recorded by the NHS Medical Genetics English Winter (Q3) 2013 287 
Dashboard National Average Figures (personal communication Chair Medical Genetics Clinical 288 
Reference Group). There is currently variation in the rate of co-counselling between different 289 
genetic services in England.  Possible reasons for such a high rate of clinical geneticist/genetic 290 
counsellor co-counselling in this service included the teams focus on providing a continuum 291 
of care for the patient aiming to maintain contact with the same genetic counsellor prior to, 292 
during and post clinic contacts.  293 
 294 
Co-counselling has been one of many historical service delivery models in the UK. Co-295 
counselling provides a multi-disciplinary approach to the holistic care of the patient and the 296 
opportunity for counsellors to focus and address different clinical and psychosocial aspects 297 
within the same consultation. Co-counselling also has benefits for the workforce as a learning 298 
opportunity for junior staff or staff expanding their scope of practice to include new areas of 299 
practice. However there are dis-advantages of co-counselling, such as the increased expense 300 
of two health professionals being present and complexities in scheduling appointments.  301 
 302 
Genetic counsellor only contacts were higher in this study at 73.1% than the English average 303 
of 44.6%. At the time of this study the service had one of the lowest proportions of medical 304 
clinical geneticists per population covered compared to the other 19 English RGS. This 305 
required the development of effective time management and support from medical clinical 306 
geneticists for joint case review enabling genetic counsellors in this service to independently 307 
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counsel for a wide range of conditions (e.g. high risk cancers, cardiac conditions, and 308 
Huntington disease).  309 
 310 
In this study, 29.1% (189/650) of referrals were not offered a clinical contact, representing 311 
indirect patient care which is not directly obvious from clinic attendance figures and could be 312 
overlooked when assessing workload.  Of these, 94 were not accepted into the service based 313 
on the English national service specification of appropriate referrals13. Many of these were 314 
patients deemed to be at moderate risk of cancer which were re-directed to a network of 315 
nurse-led family history screening clinics based within oncology services. Patients re-directed 316 
to these services saw a ‘specialism-specific genetic nurse’ (SSGN), a registered nurse working 317 
at a specialist level of practice in a clinical specialism but with additional genetics training. A 318 
UK evaluation has shown these roles to be acceptable to patients and effective in terms of 319 
improving patient access to genetic information and tests31 32 33. 320 
 321 
This study is novel as it provides the first empirical evidence of the contribution of genetic 322 
counsellors within a UK regional genetic service multi-disciplinary team.  Study limitations 323 
include that it describes the experience of a cohort of incoming referrals for a period of only 324 
3 months in one centre. The practice of this one service may not be representative of other 325 
services across the UK. 326 
 327 
Use of Initial Clinical Contact Guidelines (ICCG) 328 
The anticipated reduction in the proportion of home visits from 26% in 2010/2011 to the 13% 329 
seen in this study (2011/2012) is thought to be a consequence of implementing revised initial 330 
clinical contact guidelines. The revised guidelines allowed for home visits to be  standardised 331 
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across the team and were provided appropriately.  The study demonstrated that it was 332 
possible using the guidelines to allocate patients into differing initial contact types based on 333 
the requirements of the specific case. However, this individualised process was difficult to 334 
merge with inflexible clinic booking systems and resulted in many separate clinic queues, 335 
increasing waiting times due to patients waiting for an initial telephone clinic ‘slot’ when other 336 
‘appointment slots’ were free in other clinics.  Of concern were the 21.9% (181/825) of 337 
contacts which were co-counselled by both a genetic counsellor and clinical geneticist, due to 338 
the time commitment required by both health professionals.   339 
Moving Forwards 340 
A decision was made to plan a service re-design to move towards a ‘one clinic fits all’ system.  341 
In this model genetic counsellors and clinical geneticists have separate clinics, booking is on a 342 
first come, first served basis. It is irrespective of the clinical condition or whether it is an initial 343 
or subsequent contact. The clinician still reserves the ability to perform a telephone 344 
counselling session within the allocated clinic slot if that would best meet the needs of the 345 
patient. For some patients a telephone contact to discuss concerns and facilitate a 346 
confirmation of diagnoses is thought to be most efficient. If the referral letter raises any 347 
specific psychosocial concerns, then the genetic counsellor can still ask for a co-counselling 348 
consultation to occur (including for predictive testing).  349 
 350 
There is on-going debate as to how to most efficiently gather family history information, an 351 
initial genetic counsellor consultation usually consists of many other elements than purely 352 
information gathering. In some services the information gathering is done by specially trained 353 
administrative staff – releasing genetic counsellor time to focus on psychosocial and 354 
educative issues.  One requirement of the ‘one clinic fits all’ model is that each genetic 355 
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counsellor and clinical geneticist are able to provide counselling for all paediatric, pre-natal, 356 
adult and cancer genetic conditions. This is not always possible and relies on a workforce that 357 
has access to and time for continuing professional development. 358 
 359 
A framework for implementation of genetic services has recently been proposed by Rigter et 360 
al. to provide structure for the transition process towards new ways of working. They defined 361 
three influencing factors: different ways of doing, different ways of thinking and different 362 
ways of organising 34. The authors proposed a process of deepening, broadening and scaling 363 
up of any new service. This framework could be used to help implement future service re-364 
design. 365 
 366 
There remains the need to evaluate the effectiveness of new service designs and how the 367 
limited workforce of clinical geneticists and genetic counsellors can be utilized to increase 368 
access to genetic services and provide safe patient care.  Currently many European countries 369 
have limited or no non-medical genetic counsellors, although with increased demand for 370 
access to specialist knowledge the cost effectiveness of genetic counsellors over clinical 371 
geneticists may become attractive. This study has demonstrated that appropriately trained 372 
and resourced genetic counsellors engaging in multi-disciplinary working practice can provide 373 
a significant proportion of patient contacts. Studies undertaken in other areas of healthcare 374 
could inform the optimum use of skill mix and multidisciplinary practice. The development of 375 
the specialism specific genetic nurse (SSGN) role within mainstream clinical specialty areas 376 
such as oncology, cardiology or endocrinology adds another route through which patients 377 
could access genetic services. Cohen et al.35 call for a shared terminology when describing 378 
genetic service delivery models. However comparison of service delivery models between and 379 
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within countries remains difficult due to the influence of social, political and historical 380 
factors36,37.  In the US a recent survey shows wide variation in genetic counsellor service 381 
delivery models, unfortunately in part this variation is explained by limits imposed by billing 382 
and bureaucracy, not always by good practice38.  383 
 384 
The methodological techniques of implementation science39, including the conduct of 385 
implementation trials and the study of complex interventions could be beneficial in building 386 
the evidence base on which to develop new ways of working to optimise skill mix and 387 
workforce utilization in genetic service delivery models40. Further research needs to be 388 
undertaken to establish how best to integrate patient reported outcome and satisfaction 389 
measures within routine genetic health service delivery.  390 
 391 
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Figure 1. Progress of the 650 new patients referred over the 3 month period 
 (12.12.2011- 12.03.2012), resulting in 825 offered contacts (12 months of follow up until 12.03.2013)
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Table 1 - Triage allocation categories for the 461 new patients who were accepted by the regional genetics service and who opted into the service.   423 
  Lead Health 
Professional  
  Initial clinical contact allocated Total 
 Genetic 
counsellor Initial 
clinical contact 
advised by triage 
guidelines 
(ICCG). 
Genetic 
Counsellor 
(GC) 
Clinical 
Geneticist 
(CG) 
Total  
 
*P value Telephone 
Clinic  (TC) 
with  
GC 
Face to 
Face (F2F) 
Clinic with 
GC 
Home 
Visit  
(HV) with 
GC 
Medical 
Clinic (CG) 
or (CG plus 
GC) 
Total (% 
within 
patient 
allocation 
category) 
Triage allocation patient 
category. 
   N      (%) N      (%)    N  
 
    N   (%)   N (%)    N (%)   N (%)   N (%) 
All other adult referrals not 
mentioned below * 
F2F    87   (69.0) 39    (31.0)  126  < 0.001    23 (18.1) 101 (79.6)    1  (0.8)   2   (1.6) 127 (29.8) 
Inherited cardiac 
conditions  clinic * 
F2F   29   (85.3)   5    (14.7)    34  < 0.001      4  (2.4)   30 (20.7)    0  (0.0)   0   (0.0)   34   (8.0) 
Predictive testing not 
cancer 
F2F     8   (80.0)   2    (20.0)    10    0.109      1  (0.6)     9   (5.0)    0  (0.0)   0   (0.0)   10   (2.3) 
Out-reach clinics with local 
face to face clinic * 
F2F     5   (25.0) 15    (75.0)    20    0.041      5 (2.9)   12   (6.7)    2  (3.6)   1   (4.8)   20   (4.7) 
Cancer predictive test * 
 
Telephone   30   (75.0) 10    (25.0)    40     0.002   32 (18.8)      6   (3.4)    1  (1.8)   1   (4.8)   40   (9.4) 
Confirmatory 
diagnostic testing 
Telephone   15   (51.7) 14    (48.3)    29     1.000   23 (13.5)      4   (2.2)    1  (1.8)   1   (4.8)   29   (6.8) 
Prenatal Telephone   10   (33.3) 20    (66.7)    30     0.099    25 (14.7)      3   (1.7)    0  (0.0)   2   (9.5)   30   (7.0) 
Paediatric patient without 
developmental delay * 
Telephone     5   (14.3) 30    (85.7)    35  < 0.001    27 (15.9)       3   (1.7)    1  (1.8)   4 (19.0)   35   (8.2) 
Family members previously 
seen by the service and 
information known * 
Telephone     5   (20.0) 20    (80.0)     25    0.004    17 (10.0)      3   (1.7)    1  (1.8)   4 (19.0)   25   (5.9) 
Patient lives on the Isle of 
Man (>50 miles) 
Telephone     3   (75.0)   1    (25.0)      4    0.625      3    (1.8)      1   (0.6)    0   (0.0)   0   (0.0)     4   (0.9) 
Any concerns regarding 
the safety of offering a 
home visit 
Telephone     0     (0.0)    1 (100.0)      1  1.000      0    (0.0)      0  (0.0)  1     (1.8)   0   (0.0)     1    (0.2) 
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Terminal care issue Home visit     2   (66.7)    1    (33.3)      3  1.000     2     (1.2)     1   (0.6)  0     (0.0)    0   (0.0)   3      (0.7) 
New significant diagnosis 
for the family * 
Home visit     2     (9.1)  20    (90.9)    22  <0.001     2     (1.2)     1   (0.6) 18 (32.1)    1   (4.8)  22     (5.2) 
Paediatric patient with 
hearing loss 
Home visit     1 (100.0)    0      (0.0)      1  1.000     0     (0.0)     1   (0.6)   0   (0.0)    0  (0.0)    1      (0.2) 
Paediatric patient with life 
threatening illness 
Home visit     1   (50.0)    1    (50.0)      2  1.000     0     (0.0)     0   (0.0)   2   (3.6)    0  (0.0)    2      (0.5) 
Paediatric with 
developmental delay * 
Home visit     0    (0.0)   32 (100.0)     32  <0.001     4     (2.4)     2   (1.2) 23 (41.1)    3 (14.3)  32      (7.5) 
Evidence of parental 
anxiety 
Home visit     0    (0.0)     1 (100.0)      1  1.000     0     (0.0)     0   (0.0)    1  (1.8)    0  (0.0)    1      (0.2) 
Recent bereavement Home visit     0    (0.0)     5 (100.0)      5  0.063     1     (0.6)     0  (0.0)    4  (7.1)    0  (0.0)    5      (1.2) 
Adult with significant 
learning difficulties 
 
Home visit 
     
    0    (0.0) 
     
     0    (0.0) 
     5 
     0  
0.063 
n/a 
1 (0.6) 
0 (0.0) 
    2  (1.2) 
    0  (0.0) 
   0  (0.0) 
   0  (0.0) 
   2  (9.5)   
   0  (0.0) 
   5      (1.2)     
   0      (0.0) 
Reply by letter +      0    (0.0)     5 (100.0)      5  0.063     1     (0.6)     2  (1.2)    0  (0.0)    2  (9.5)    5      (1.2) 
Missing category    10  (27.8)                    26 ( 72.2)    36       
 
Sub-total 
 
  
213 
(46.2%) 
 
248 
(53.8%) 
  
 
 
170  (39.3) 
 
179 (42.0) 
 
56 (13.2) 
 
21   (4.9) 
 
426 (100) 
missing 35 
Total   213 246  461      461 
Initial clinical contact types. 
F2F = 1 hour clinic appointment with only a genetic counsellor at health centre or hospital. 
Telephone = 45 minutes – 1 hour booked telephone appointment with only a genetic counsellor. 
Home visit = 1 hour appointment where the genetic counsellor would travel to the patients home (most patients lived within one hour drive from the service 
base).  
+ These 5 patients are included here as they were initially triaged as reply by letter but were subsequently offered an appointment. 
* Using a 5% significance level without adjustment for multiple testing for identifying triage decision where there is a significant bias in preference for either 
genetic counsellor or clinical geneticist lead.  
ICCG = Initial clinical contact triage guidelines 
GC = UK non-medical genetic counsellor 
CG = UK Medical clinical geneticist 
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Table 2 – Number of patient contacts offered to the 461 patients opting into the service. 426 
 427 
 Number of patient contacts offered to the 461 patients. 
 
 
Health Professionals 
Present 
 
Initial 
Contact 
 
Contact 2 Contact 3 Contact 4  Total 
Genetic Counsellor Only 
 
432 (93.7%) 
 
  74   (25.3%) 25  (45.4%) 11  (68.8%)  542     (65.7%) 
Genetic Counsellor/Genetic 
Counsellor co-counselled 
 
    0   (0.0%)   38   (13.0%) 19  (34.6%)   4  (25.0%)    61       (7.4%) 
Clinical Geneticist/Genetic 
Counsellor co-counselled 
    0   (0.0%) 170  (58.0%) 10  (18.2%)   1    (6.2%)   181    (21.9%) 
Clinical Geneticist only   29  (6.3%) 
 
  11    (3.7%)   1    (1.8%)   0    (0.0%)     41      (5.0%) 
Total 461 (55.9%) 
 
293  (35.5%) 55    (6.7%) 16    (1.9%)     825  (100.0%) 
 428 
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 430 
 431 
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Figure Legend(s): 
Table 1 - Triage allocation categories for the 461 new patients who were accepted by the regional genetics service and who opted into the service.   
Table 2 - Number of patient contacts offered to the 461 patients who opted into the service. 
Figure 1 – Progress of the 650 new patients referred over the 3 month period (12.12.2011-12.03.2012), resulting in 825 offered contacts – with 12 months 
of follow up until 12.03.2013. 
Figure 2 – Patient satisfaction with the genetics service as measured by the Zellerino satisfaction questionnaire (97/388). 
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Supplementary material 
1. Referral management form September 2011  
2. Triage category sheet 2012 (ICCG) Initial Clinical Contact Guidelines. 
3. Genetic Counselling Brochure sent to patients following referral to the service. 
4. Hospital out-patient clinic letter inviting patients to opt-into the service. 
5. New referral management form 2014  
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